Additional Analyses for the Published Primary Norfloxacin Prophylaxis for APASL-Defined Acute-on-Chronic Liver Failure

Am J Gastroenterol. 2022 May 1;117(5):814-815. doi: 10.14309/ajg.0000000000001702. Epub 2022 Mar 22.

Authors

Dominic Crocombe¹, Nick Freemantle², Alastair O'Brien^{1

2}; ASEPTIC trial team

Affiliations

¹ Institute of Liver and Digestive Health, University College London, London, UK.
² Comprehensive Clinical Trials Unit, University College London, London, UK.

PMID: 35318292
DOI: 10.14309/ajg.0000000000001702

No abstract available

Publication types

Comment

MeSH terms

Acute-On-Chronic Liver Failure*
Humans
Liver Cirrhosis / drug therapy
Norfloxacin / therapeutic use

Substances

Norfloxacin